MyAlcon | United Kingdom

This page is available in English. Select below for other countries.

MyAlcon | Country

This page is available in English. Select below for other countries.

MyAlcon Global Sites

Americas

     Canada - English / Français

     United States - English

 
Europe / Middle East / Africa
     United Kingdom - English

     Germany - Deutsch

     Switzerland - Deutsch

     Norway - Norwegian

     Sweden - Swedish

     Denmark - Danish

     Finland - Finnish

     Netherlands - Nederlands

 
Asia Pacific

     Australia - English

     India - English

     Japan - Japanese

 

COMING SOON

Americas
     Brazil
     Mexico
     Colombia
     Chile
     Argentina
     Ecuador
     Peru
     Uruguay
 
Europe / Middle East / Africa
     Spain
     Italy
     France

 

Asia Pacific
     South Korea
     China
     Hong Kong
     Singapore

Systane® BALANCE

Long-lasting relief³ for lipid deficient dry eye


Key Benefits

Systane® BALANCE is designed for lipid deficient (Evaporative) Dry Eye, especially for meibomian gland dysfunction (MGD) sufferers¹ :

  • Restores the lipid layer1.
  • Protects against ecaporation1.
  • Relief from Dry Eye symptoms especially for MGD sufferers¹ ²

 

Systane BALANCE pack shot

Features & Technology

 

  • Unique composition with LipiTech™ designed to help rebuild the lipid-layer and stabilise the tear film.
  • Exclusive combination of ingredients locks in moisture².
  • Easy dosing due to the handy Drop-Tainer™ bottle.

 

Features and Technology

Patient Benefits

 

  • Ideal for patients with lipid deficient (Evaporative) Dry Eye, especially those who suffer from (MGD)² ³.
  • Also suitable for moderate, chronic sufferers*
  • Can use before or after wearing contact lenses**

 

 

 

Woman sitting outside

*Based on internal assessment and patient segmentation
**Please refer to instructions for use

 

References:

  1. Sindt, C.W. and Foulks, G.N. 2013. Efficacy of an artificial tear emulsion in patients with dry eye associated with meibomian gland dysfunction. Clinical Ophthalmology (Auckland, NZ), 7, p.1713.
  2. Korb DR, Blackie CA, Meadows DL, Christensen M, Tudor M. Evaluation of extended tear stability by two emulsion based artificial tears. Poster presented at: 6th International Conference on the Tear Film and Ocular Surface: Basic Science and Clinical Relevance; September 22-25, 2010; Florence, Italy.